← Back to Search

Active Comparator, Residential density-located venue placement strategy for Health Behaviors (OSJP Trial)

N/A

Waitlist Available

Led By Leslie D Leve, PhD

Research Sponsored by University of Oregon

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one time point only (~15 minute survey), when a participant engages in covid-19 testing at a testing site, no longitudinal follow-up

Awards & highlights

OSJP Trial Summary

This trial is testing a "partner-optimized venue placement strategy" to see if it yields more Latinx individuals tested than placement of sites based upon residential density used in the ongoing testing in Phase I of this study.

Eligible Conditions

Health Behaviors
Health Care Utilization

OSJP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one time point only (~15 minute survey), when a participant engages in covid-19 testing at a testing site, no longitudinal follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one time point only (~15 minute survey), when a participant engages in covid-19 testing at a testing site, no longitudinal follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and one time point only (~15 minute survey), when a participant engages in covid-19 testing at a testing site, no longitudinal follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COVID-19 Prevention Health Behaviors

Latinx testing engagement

RADx Common Data Elements - Vaccination Questions

+2 more

OSJP Trial Design

2Treatment groups

Experimental Treatment

Group I: Partner-optimized venue placement strategyExperimental Treatment1 Intervention

The Phase II intervention involves outreach from community partners to attend testing at existing events organized by community partners, such as the Mexican Consulate. At the event, it includes the on-site Promotores de Salud psychoeducation related to SARS-CoV-2 health related behaviors.

Group II: Active Comparator, Residential density-located venue placement strategyExperimental Treatment1 Intervention

This is the Phase I intervention (Clinical Trial ID: NCT04793464). It includes the Phase I Promotores de Salud intervention, which consists of outreach to promote testing and vaccination at re-occurring testing events that have been selected for sites that have a high residential density of Latinx persons. At the testing events, it includes the on-site Promotores de Salud psychoeducation related to SARS-CoV-2 health related behaviors.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Phase II Promotores de Salud

2021

N/A

~1470

Phase I Promotores de Salud Outreach

2021

N/A

~1470

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor

80 Previous Clinical Trials

45,296 Total Patients Enrolled

4 Trials studying Health Behaviors

2,582 Patients Enrolled for Health Behaviors

National Institute on Drug Abuse (NIDA)NIH

2,464 Previous Clinical Trials

2,617,130 Total Patients Enrolled

5 Trials studying Health Behaviors

2,595 Patients Enrolled for Health Behaviors

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,951,125 Total Patients Enrolled

13 Trials studying Health Behaviors

6,687 Patients Enrolled for Health Behaviors

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open for this investigation?

"Confirmed by clinicaltrials.gov, this trial is still open for enrollment and has been accepting applicants since September 15th 2021. The study was last edited on October 3rd 2022."

Answered by AI

How many persons are engaged in this experiment?

"Affirmative. According to clinicaltrials.gov, this research is currently seeking participants who can be enrolled at 1 location and make up the 1100 patient target set on September 15th 2021. The study's progress has been updated as recently as October 3rd 2022"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II

Leslie Leve, 2021. "COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05082935.